EUVIMEDEUVIMED entdecken
Open Access

Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets

Ram J Tharu iD, Yusha Imtiaz iD, Shubhajit Singha iD, Emmett Hanson iD, Reggie E Gold iD, Pavl Royzen, Mehmet V Yigit iD

Small Methods · 2026

DOI: 10.1002/smtd.71075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2026. Verfasst von Ram J Tharu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University At Albany, State University of New York, Albany, New York, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, CRISPR-Cas Systems, CRISPR-Associated Proteins, Endodeoxyribonucleases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The programmability of CRISPR‐Cas12a has enabled transformative advances in nucleic acid detection; however, extending its activation to non‐nucleic‐acid targets remains highly desirable. Here, we report a universal split‐activator strategy that enables programmable Cas12a activation in response to a small molecule and a protein. In this approach, a canonical activator is divided into two fragments (p1 and p2), such that Cas12a activation occurs only upon their simultaneous assembly. We integrate this mechanism with aptamer‐mediated conformation switching, wherein target binding destabilizes an aptamer‐p2 duplex, releasing p2 to complete the activator complex and trigger Cas12a nuclease activity. Using this design, we demonstrate selective recognition of the small‐molecule metabolite adenosine and the protein biomarker prostate‐specific antigen (PSA), with high specificity against structurally related controls. Signal generation is achieved using fluorescent DNA nanoclusters (DFN‐1), which undergo fluorescence decrease upon Cas12a‐mediated degradation. The system exhibits concentration‐dependent responses for both targets. Together, this work establishes a modular framework for coupling aptamer‐based molecular recognition to programmable Cas12a activation, expanding the functional scope of CRISPR systems beyond nucleic acids and enabling new opportunities in CRISPR‐Cas12a‐mediated detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideCRISPR-Cas SystemsCRISPR-Associated ProteinsEndodeoxyribonucleasesBacterial ProteinsHumansAdenosineProstate-Specific AntigenBiosensing TechniquesDNA NanostructuresDNA

Stichwörter der Autor:innen

Cas12aDNA nanoclustersaptamerbiosensingfluorescencesplit activator

Substanzen

Aptamers, NucleotideCRISPR-Associated ProteinsAdenosineEndodeoxyribonucleasesProstate-Specific AntigenCas12a proteinBacterial ProteinsDNA

Autor:innen und Institutionen

  • Department of Chemistry, University At Albany, State University of New York, Albany, New York, USA.
  • The RNA Institute, University At Albany, State University of New York, Albany, New York, USA.

ORCID-Profile: Ram J Tharu, Yusha Imtiaz, Shubhajit Singha, Emmett Hanson, Reggie E Gold, Mehmet V Yigit

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Tharu, R. J., Imtiaz, Y., Singha, S., Hanson, E., Gold, R. E., Royzen, P., & Yigit, M. V. (2026). Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets. Small Methods. https://doi.org/10.1002/smtd.71075

Vancouver

Tharu RJ, Imtiaz Y, Singha S, Hanson E, Gold RE, Royzen P, et al. Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets. Small Methods. 2026. doi:10.1002/smtd.71075

BibTeX
@article{Tharu2026,
  author = {Tharu, Ram J and Imtiaz, Yusha and Singha, Shubhajit and Hanson, Emmett and Gold, Reggie E and Royzen, Pavl and Yigit, Mehmet V},
  title = {Split Activator Assembly via Aptamer Binding Enables CRISPR‐Cas12a Activation With Non‐Nucleic Acid Targets},
  journal = {Small Methods},
  year = {2026},
  doi = {10.1002/smtd.71075}
}
Kostenlos starten →